FTP 198
Alternative Names: FTP-198Latest Information Update: 28 Mar 2024
At a glance
- Originator Haisco Pharmaceutical Group
- Class Antifibrotics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Idiopathic pulmonary fibrosis
Most Recent Events
- 28 Mar 2024 No recent reports of development identified for preclinical development in Idiopathic-pulmonary-fibrosis in China (PO, Suspension)
- 28 Jan 2024 No recent reports of development identified for phase-I development in Idiopathic-pulmonary-fibrosis(In volunteers, In adults) in China (PO, Tablet)
- 28 Sep 2023 No recent reports of development identified for preclinical development in Idiopathic-pulmonary-fibrosis in China (PO, Capsule)